Mutated EPHA2 is a target for combating lymphatic metastasis in intrahepatic cholangiocarcinoma.
Sheng Y, Wei J, Zhang Y, Gao X, Wang Z, Yang J, Yan S, Zhu Y, Zhang Z, Xu D, Wang C, Zheng Y, Dong Q, Qin L.
Sheng Y, et al. Among authors: xu d.
Int J Cancer. 2019 May 15;144(10):2440-2452. doi: 10.1002/ijc.31979. Epub 2019 Jan 11.
Int J Cancer. 2019.
PMID: 30412282